Praxis Precision Medicines shares traded on the Nasdaq exchange, while RBC Capital reaffirmed Buy rating and HC Wainwright maintained Buy rating and revised EPS forecasts.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Praxis Precision Medicines shares traded on the Nasdaq exchange, while RBC Capital reaffirmed Buy rating and HC Wainwright maintained Buy rating and revised EPS forecasts.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
RBC Capital Markets
global investment bank
Related events
- Praxis Precision Medicines listed its shares on the Nasdaq stock exchange on July 17, 2026.
- Praxis Precision Medicines and Relay Therapeutics were listed on the Nasdaq stock exchange on October 1, 2026.
- Privia Health Group, Inc. shares are listed on the Nasdaq exchange, and Citigroup reissued a buy rating on the stock.
- FirstCash traded on the Nasdaq stock exchange, filed required reports with the SEC, and saw its stock price affected by analyst ratings.
- CleanSpark traded on the Nasdaq stock exchange, and Citigroup provided research reports and ratings.